These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 7856099)
21. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines. Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616 [TBL] [Abstract][Full Text] [Related]
22. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717 [TBL] [Abstract][Full Text] [Related]
23. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Finke J; Fritzen R; Ternes P; Trivedi P; Bross KJ; Lange W; Mertelsmann R; Dölken G Blood; 1992 Jul; 80(2):459-69. PubMed ID: 1378321 [TBL] [Abstract][Full Text] [Related]
24. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996 [TBL] [Abstract][Full Text] [Related]
25. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection. Contreras-Salazar B; Ehlin-Henriksson B; Klein G; Masucci MG J Virol; 1990 Nov; 64(11):5441-7. PubMed ID: 2170681 [TBL] [Abstract][Full Text] [Related]
26. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531 [TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome. Le Roux F; Sergeant A; Corbo L J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788 [TBL] [Abstract][Full Text] [Related]
28. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. Schaefer BC; Strominger JL; Speck SH J Virol; 1995 Aug; 69(8):5039-47. PubMed ID: 7609074 [TBL] [Abstract][Full Text] [Related]
29. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Puglielli MT; Woisetschlaeger M; Speck SH J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191 [TBL] [Abstract][Full Text] [Related]
30. Susceptibility to HIV-1 infection of a human B-lymphoblastoid cell line, DG75, transfected with subgenomic DNA fragments of Epstein-Barr virus. Goldblum N; Daefler S; Llana T; Ablashi D; Josephs S; Salahuddin Z Dev Biol Stand; 1990; 72():309-13. PubMed ID: 2178126 [TBL] [Abstract][Full Text] [Related]
31. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells. Doyle MG; Crawford DH Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878 [TBL] [Abstract][Full Text] [Related]
32. Activation of human thymocytes after infection by EBV. Paterson RL; Kelleher CA; Streib JE; Amankonah TD; Xu JW; Jones JF; Gelfand EW J Immunol; 1995 Feb; 154(3):1440-9. PubMed ID: 7822809 [TBL] [Abstract][Full Text] [Related]
33. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells. Kryworuckho M; Diaz-Mitoma F; Kumar A Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880 [TBL] [Abstract][Full Text] [Related]
34. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters. Gutsch DE; Marcu KB; Kenney SC Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):747-60. PubMed ID: 7812182 [TBL] [Abstract][Full Text] [Related]
35. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Kube D; Platzer C; von Knethen A; Straub H; Bohlen H; Hafner M; Tesch H Cytokine; 1995 Jan; 7(1):1-7. PubMed ID: 7749063 [TBL] [Abstract][Full Text] [Related]
36. B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter. Contreras-Brodin B; Karlsson A; Nilsson T; Rymo L; Klein G J Gen Virol; 1996 Jun; 77 ( Pt 6)():1159-62. PubMed ID: 8683201 [TBL] [Abstract][Full Text] [Related]
37. Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. Minarovits J; Hu LF; Imai S; Harabuchi Y; Kataura A; Minarovits-Kormuta S; Osato T; Klein G J Gen Virol; 1994 Jan; 75 ( Pt 1)():77-84. PubMed ID: 8113742 [TBL] [Abstract][Full Text] [Related]
39. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Schaefer BC; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841 [TBL] [Abstract][Full Text] [Related]
40. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death. Inman GJ; Binné UK; Parker GA; Farrell PJ; Allday MJ J Virol; 2001 Mar; 75(5):2400-10. PubMed ID: 11160743 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]